The value of spectral CT quantitative parameters in predicting Ki-67 level in ovarian cancer

The value of spectral CT quantitative parameters in predicting Ki-67 level in ovarian cancer

ObjectiveThe objective of this study is to evaluate the predictive value of quantitative parameters from spectral CT for Ki-67 expression in ovarian cancer (OC).MethodsSpectral CT imaging data from 39 patients with ovarian cancer by pathology, encompassing 52 lesions overall, were collected retrospe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Siwen Pang, Meng Wu, Haijia Yu, Tiantian Ma, Jianhua Liu, Siwen Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Oncology
Subjects:	ovarian cancer Ki-67 level quantitative parameters iodine concentration effective atomic number the slope of the spectral curve
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1576690/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neoplasias astrocitárias e correlação com as proteínas p53 mutada e Ki-67 Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins
by: Gustavo Rassier Isolan, et al.
Published: (2005-12-01)

Prediction of Ki-67 expression in gastric gastrointestinal stromal tumors using histogram analysis of monochromatic and iodine images derived from spectral CT
by: Xianwang Liu, et al.
Published: (2024-12-01)

Association between histologic grades and Ki67 score in breast cancer
by: Dr Shumaila Nawaz Khan Khan, et al.
Published: (2025-03-01)

The association between Ki-67 expression and survival in breast cancer subtypes: a cross-sectional study of Ki-67 cut-point in northern Thailand
by: Phanchaporn Wongmaneerung, et al.
Published: (2025-02-01)

Immunohistochemical Staining Properties of Osteopontin and Ki-67 in Feline Meningiomas
by: Gabriele Gradner, et al.
Published: (2024-11-01)

Evaluation of Ki-67 expression levels in esophageal squamous cell carcinoma using dual-energy CT quantitative parameters
by: Jing Sun, et al.
Published: (2025-08-01)

P63 and Ki-67 expression in radicular cyst
by: Mohammed Amjed Alsaegh, et al.
Published: (2023-09-01)

The importance of Ki-67 proliferation index in small cell lung cancer
by: Seda Beyhan Sağmen, et al.
Published: (2025-01-01)

Prognostic significance of Ki-67 in assessing the risk of progression, relapse or metastasis in pheochromocytomas and paragangliomas
by: Zilan Luo, et al.
Published: (2025-12-01)

A correlation research of Ki67 index, CT features, and risk stratification in gastrointestinal stromal tumor
by: Huali Li, et al.
Published: (2018-09-01)

A deep learning model to predict Ki-67 positivity in oral squamous cell carcinoma
by: Francesco Martino, et al.
Published: (2024-12-01)

Blood biomarkers and Ki-67 proliferation marker in breast cancer
by: A. A. Studenikina, et al.
Published: (2023-04-01)

Metastatic prolactinoma: case report with immunohistochemical assessment for p53 and Ki-67 antigens Prolactinoma metastático: relato de caso com avaliação imuno-histoquímica para os antígenos p53 e Ki-67
by: Paulo S. Crusius, et al.
Published: (2005-09-01)

Expression of Ki-67 in Oral Lichen Planus: A Systematic Review and Meta-Analysis
by: Ayla Bahramian, et al.
Published: (2024-12-01)

MRI-based multiregional radiomics for preoperative prediction of Ki-67 expression in meningiomas: a two-center study
by: Ming Luo, et al.
Published: (2025-07-01)

Prognostic Importance of Ki-67 Expression in Early-Stage Glottic Larynx Cancer Treated with Radiotherapy
by: Gül Kanyılmaz, et al.
Published: (2023-10-01)

Cyclooxygenase-2 and Ki67 Expression in Oral Leukoplakia: a Clinicopathological Study
by: Alper Sinanoglu, et al.
Published: (2015-06-01)

Ki67 index importance in patients with breast cancer
by: O. Bondar
Published: (2024-12-01)

Assessment of the Relationship between Ki-67 Expression and Different Clinicopathological Factors of Adenoid Cystic Carcinoma: A Retrospective Immunohistochemical Study
by: Mohammed Al Zubidi, et al.
Published: (2025-03-01)

Prediction of Ki-67 Expression in HIV-Associated Lung Adenocarcinoma Patients Using Multiple Machine Learning Models Based on CT Imaging Radiomics
by: Song C, et al.
Published: (2025-04-01)

Role of topoisomerase II α and Ki -67 biomarkers in pituitary tumors
by: Chhanda Das, et al.
Published: (2023-12-01)

Interpretable model based on MRI radiomics to predict the expression of Ki-67 in breast cancer
by: Li Zhang, et al.
Published: (2025-04-01)

Development and validation of a model based on preoperative dual-layer detector spectral computed tomography 3D VOI-based quantitative parameters to predict high Ki-67 proliferation index in pancreatic ductal adenocarcinoma
by: Dan Zeng, et al.
Published: (2024-12-01)

BIOLOGICAL MARKERS OF THE Ki-67 CELL CYCLE AND Bcl-2 IN MYOMA, ADENOMYOSIS, AND LEIOMYOSARCOMA UTERI
by: Светлана Владимировна Шрамко, et al.
Published: (2019-09-01)

Investigation of Ki-67 and Clinical Outcome in Feline Nasal Adenocarcinoma Treated Using Hypofractionated Radiotherapy
by: Premkamon Aonta, et al.
Published: (2024-12-01)

The impact of stratified management of Ki-67 on the prognosis of small-cell lung cancer
by: Xiaofang Zhang, et al.
Published: (2025-07-01)

A study of histopathological spectrum and expression of Ki-67, TP53 in primary brain tumors of pediatric age group
by: Subhalakshmi Sengupta, et al.
Published: (2012-01-01)

Ki-67—Playing a key role in breast cancer but difficult to apply precisely in the real world
by: Changsong Wang, et al.
Published: (2025-05-01)

The correlation between Ki-67 with other prognostic factors in breast cancer: A study in Iranian patients
by: Seyed-Hamid Madani, et al.
Published: (2016-01-01)

Preoperative multiparameter MRI‐based prediction of Ki‐67 expression in primary central nervous system lymphoma
by: Jian Xu, et al.
Published: (2025-03-01)

Study of Immunohistochemical Expression of p53 and Ki-67 in Oral Squamous Cell Carcinoma
by: Kajal Ranjan, et al.
Published: (2025-08-01)

Multi-center study: ultrasound-based deep learning features for predicting Ki-67 expression in breast cancer
by: Qishan Cen, et al.
Published: (2025-03-01)

PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF KI67 DYNAMIC CHANGE DURING PREOPERATIVE ENDOCRINE THERAPY IN BREAST CNACER PATIENTS
by: M. V. Rodionova, et al.
Published: (2016-02-01)

Effect of expression of immunohistochemical marker Ki-67 on the life expectancy of patients with gastric cancer 0-III stages
by: O. M. Levyk, et al.
Published: (2015-08-01)

A Case of a Rapidly Progressive Small Bowel Lymphoma with High Ki-67 Expression
by: Jiyeon Yoo, et al.
Published: (2017-03-01)

Expression of cytokeratin 7/20 and Ki67 in Helicobacter pylori-associated gastritis and intestinal metaplasia
by: Ava T Ismael, et al.
Published: (2024-07-01)

Clinicopathological importance of immunohistochemical expression of OCT4, c-MYC and Ki-67 in colorectal cancer
by: Rabia Hursitoglu, et al.
Published: (2024-12-01)

Association between Ki-67 and clinical outcomes in 324 Chinese patients with resectable acral melanoma
by: Yi Teng, et al.
Published: (2025-08-01)

Improving the accuracy of reporting Ki-67 IHC by using an AI tool
by: Sahil Ajit Saraf, et al.
Published: (2024-11-01)

Integrating traditional biomarkers and emerging predictors to assess neoadjuvant chemotherapy efficacy in breast cancer: a multifactorial analysis of Ki-67, CDK4, EGFR, TILs and ctDNA
by: Tianzhao Du, et al.
Published: (2024-12-01)